CHSU Discovery

AMPK Signaling Pathway as a Potential Therapeutic Target for Parkinson's Disease

Advanced pharmaceutical bulletin
volume 14 issue 1 pages 120-131
March 2024

Repository

Description

Parkinson's disease (PD) is the second most common neurodegenerative disease caused by the loss of dopaminergic neurons. Genetic factors, inflammatory responses, oxidative stress, metabolic disorders, cytotoxic factors, and mitochondrial dysfunction are all involved in neuronal death in neurodegenerative diseases. The risk of PD can be higher in aging individuals due to decreased mitochondrial function, energy metabolism, and AMP-activated protein kinase (AMPK) function. The potential of AMPK to regulate neurodegenerative disorders lies in its ability to enhance antioxidant capacity, reduce oxidative stress, improve mitochondrial function, decrease mitophagy and macroautophagy, and inhibit inflammation. In addition, it has been shown that modulating the catalytic activity of AMPK can protect the nervous system. This article reviews the mechanisms by which AMPK activation can modulate PD.

Show Full Abstract Collapse Abstract

Affiliations

  1. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  2. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  3. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  4. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Department of Biomedical Education, California Health Sciences University, College of Osteopathic Medicine, Clovis, CA, USA.

Publisher

Maad Rayan Publishing Company
Loading...